| Dr William C Pederson, MD | |
|
6701 Fannin St Ste 610.00, Houston, TX 77030-2608 | |
| (832) 822-3180 | |
| Not Available |
| Full Name | Dr William C Pederson |
|---|---|
| Gender | Male |
| Speciality | Plastic Surgery |
| Location | 6701 Fannin St Ste 610.00, Houston, Texas |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1053387902 | NPI | - | NPPES |
| 133003703 | Medicaid | TX |
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053352914 PECOS PAC ID: 8224941265 Enrollment ID: O20031106000562 |
News Archive
A new technique that can spot a potential preterm birth in asymptomatic high-risk women, with up to 73% accuracy months before delivery, has been developed by scientists at the University of Warwick.
A coronavirus test made by Abbott Laboratories and introduced with considerable fanfare by President Donald Trump in a Rose Garden news conference this week is giving state and local health officials very little added capacity to perform speedy tests needed to control the COVID-19 pandemic.
BioSante Pharmaceuticals, Inc. has announced the publication of positive results of a preclinical study of its proprietary calcium phosphate nanoparticle (CAP) delivery system for the oral delivery of insulin in the June 11 issue of the peer-reviewed International Journal of Pharmaceutics.
University of Houston associate professor of biomedical engineering Nuri Ince, who pioneered a dramatic decrease in the time it takes to detect the seizure onset zone in the brain, has been awarded $2.3 million by the National Institutes of Health to expand his testing in a large number of adult and pediatric epilepsy cases.
› Verified 5 days ago
| Entity Name | Children's Physician Services Of South Texas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568658227 PECOS PAC ID: 3678478872 Enrollment ID: O20040324001704 |
News Archive
A new technique that can spot a potential preterm birth in asymptomatic high-risk women, with up to 73% accuracy months before delivery, has been developed by scientists at the University of Warwick.
A coronavirus test made by Abbott Laboratories and introduced with considerable fanfare by President Donald Trump in a Rose Garden news conference this week is giving state and local health officials very little added capacity to perform speedy tests needed to control the COVID-19 pandemic.
BioSante Pharmaceuticals, Inc. has announced the publication of positive results of a preclinical study of its proprietary calcium phosphate nanoparticle (CAP) delivery system for the oral delivery of insulin in the June 11 issue of the peer-reviewed International Journal of Pharmaceutics.
University of Houston associate professor of biomedical engineering Nuri Ince, who pioneered a dramatic decrease in the time it takes to detect the seizure onset zone in the brain, has been awarded $2.3 million by the National Institutes of Health to expand his testing in a large number of adult and pediatric epilepsy cases.
› Verified 5 days ago
| Entity Name | Hand Center Pa |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1154398949 PECOS PAC ID: 9537127147 Enrollment ID: O20041229000702 |
News Archive
A new technique that can spot a potential preterm birth in asymptomatic high-risk women, with up to 73% accuracy months before delivery, has been developed by scientists at the University of Warwick.
A coronavirus test made by Abbott Laboratories and introduced with considerable fanfare by President Donald Trump in a Rose Garden news conference this week is giving state and local health officials very little added capacity to perform speedy tests needed to control the COVID-19 pandemic.
BioSante Pharmaceuticals, Inc. has announced the publication of positive results of a preclinical study of its proprietary calcium phosphate nanoparticle (CAP) delivery system for the oral delivery of insulin in the June 11 issue of the peer-reviewed International Journal of Pharmaceutics.
University of Houston associate professor of biomedical engineering Nuri Ince, who pioneered a dramatic decrease in the time it takes to detect the seizure onset zone in the brain, has been awarded $2.3 million by the National Institutes of Health to expand his testing in a large number of adult and pediatric epilepsy cases.
› Verified 5 days ago
| Entity Name | Texas Childrens Physician Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1861675506 PECOS PAC ID: 4385722081 Enrollment ID: O20080422000209 |
News Archive
A new technique that can spot a potential preterm birth in asymptomatic high-risk women, with up to 73% accuracy months before delivery, has been developed by scientists at the University of Warwick.
A coronavirus test made by Abbott Laboratories and introduced with considerable fanfare by President Donald Trump in a Rose Garden news conference this week is giving state and local health officials very little added capacity to perform speedy tests needed to control the COVID-19 pandemic.
BioSante Pharmaceuticals, Inc. has announced the publication of positive results of a preclinical study of its proprietary calcium phosphate nanoparticle (CAP) delivery system for the oral delivery of insulin in the June 11 issue of the peer-reviewed International Journal of Pharmaceutics.
University of Houston associate professor of biomedical engineering Nuri Ince, who pioneered a dramatic decrease in the time it takes to detect the seizure onset zone in the brain, has been awarded $2.3 million by the National Institutes of Health to expand his testing in a large number of adult and pediatric epilepsy cases.
› Verified 5 days ago
| Entity Name | Baylor College Of Medicine |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1881026664 PECOS PAC ID: 8022243971 Enrollment ID: O20131030000972 |
News Archive
A new technique that can spot a potential preterm birth in asymptomatic high-risk women, with up to 73% accuracy months before delivery, has been developed by scientists at the University of Warwick.
A coronavirus test made by Abbott Laboratories and introduced with considerable fanfare by President Donald Trump in a Rose Garden news conference this week is giving state and local health officials very little added capacity to perform speedy tests needed to control the COVID-19 pandemic.
BioSante Pharmaceuticals, Inc. has announced the publication of positive results of a preclinical study of its proprietary calcium phosphate nanoparticle (CAP) delivery system for the oral delivery of insulin in the June 11 issue of the peer-reviewed International Journal of Pharmaceutics.
University of Houston associate professor of biomedical engineering Nuri Ince, who pioneered a dramatic decrease in the time it takes to detect the seizure onset zone in the brain, has been awarded $2.3 million by the National Institutes of Health to expand his testing in a large number of adult and pediatric epilepsy cases.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr William C Pederson, MD 6701 Fannin St Ste 610.00, Houston, TX 77030-2608 Ph: (832) 822-3180 | Dr William C Pederson, MD 6701 Fannin St Ste 610.00, Houston, TX 77030-2608 Ph: (832) 822-3180 |
News Archive
A new technique that can spot a potential preterm birth in asymptomatic high-risk women, with up to 73% accuracy months before delivery, has been developed by scientists at the University of Warwick.
A coronavirus test made by Abbott Laboratories and introduced with considerable fanfare by President Donald Trump in a Rose Garden news conference this week is giving state and local health officials very little added capacity to perform speedy tests needed to control the COVID-19 pandemic.
BioSante Pharmaceuticals, Inc. has announced the publication of positive results of a preclinical study of its proprietary calcium phosphate nanoparticle (CAP) delivery system for the oral delivery of insulin in the June 11 issue of the peer-reviewed International Journal of Pharmaceutics.
University of Houston associate professor of biomedical engineering Nuri Ince, who pioneered a dramatic decrease in the time it takes to detect the seizure onset zone in the brain, has been awarded $2.3 million by the National Institutes of Health to expand his testing in a large number of adult and pediatric epilepsy cases.
› Verified 5 days ago
Dr. Cara Ryan Downey, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 2500 West Loop S, Suite 150, Houston, TX 77027 Phone: 713-496-2427 | |
Dr. Camille G Cash, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 2150 Richmond Ave., Suite 103, Houston, TX 77098 Phone: 713-571-0600 Fax: 713-571-0601 | |
Alexander F Mericli, M.D. Plastic Surgery Medicare: Accepting Medicare Assignments Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 | |
Dr. James Tang, M.D. Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 11302 Fallbrook Dr, Suite 304, Houston, TX 77065 Phone: 281-955-0115 Fax: 281-955-0116 | |
Dr. Philip James Hanwright, M.D. Plastic Surgery Medicare: Medicare Enrolled Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 | |
David Krijgh, MD Plastic Surgery Medicare: Not Enrolled in Medicare Practice Location: 1400 Pressler St, Houston, TX 77030 Phone: 713-794-5493 |